Bridging Brain and Behavior: An Integrative Approach to Neurology, Psychiatry, and Neuro-Surgical Care
DOI:
https://doi.org/10.64784/173Keywords:
brain–mind continuum, neuropsychiatry, neural circuits, neuroinflammation, precision psychiatry, neuroimaging, cognitive dysfunction, interdisciplinary care, perioperative neurocognitive disorders, global healthAbstract
The growing convergence between neurology and psychiatry has led to the emergence of the brain–mind continuum as a unifying framework for understanding disorders affecting cognition, behavior, and neurological function. This review aims to analyze and synthesize recent high-impact evidence on the integration of neurological and psychiatric perspectives in modern clinical practice, including implications for general surgery and hospital-based care. A structured narrative review was conducted using 20 peer-reviewed articles published from 2020 onward, selected from major scientific databases and journals. The analysis focused on shared neurobiological mechanisms, overlapping clinical manifestations, perioperative implications, and international applicability, particularly in healthcare systems such as those of Mexico, Colombia, and Ecuador. The results demonstrate that neural circuitry dysfunction, genetic factors, and neuroinflammatory processes constitute common pathways across a wide range of conditions. Additionally, significant overlap was identified in clinical presentations, including mood, cognitive, and behavioral disturbances. Emerging approaches such as neuroimaging, computational psychiatry, biomarkers, and precision medicine further support an integrative model of care. The findings highlight the limitations of traditional categorical classifications and emphasize the need for interdisciplinary diagnostic and therapeutic strategies. In conclusion, the brain–mind continuum represents a clinically relevant and scientifically supported framework that enhances patient care, promotes interdisciplinary collaboration, and provides a foundation for future research and medical education.
References
[1] D. S. Baldwin et al., “Mental health disorders in neurological disease: A global perspective,” Lancet Neurology, vol. 19, no. 2, pp. 179–190, 2020. doi: 10.1016/S1474-4422(19)30440-5
[2] T. A. Insel, “Digital phenotyping: Technology for a new science of behavior,” JAMA, vol. 323, no. 6, pp. 497–498, 2020. doi: 10.1001/jama.2019.20078
[3] S. Friston et al., “Computational psychiatry: From neuroscience to clinical applications,” Nature Neuroscience, vol. 23, pp. 123–133, 2020. doi: 10.1038/s41593-019-0550-1
[4] E. J. Nestler and S. E. Hyman, “Animal models of neuropsychiatric disorders,” Nature Neuroscience, vol. 23, pp. 1161–1169, 2020. doi: 10.1038/s41593-020-0630-2
[5] M. F. Caspi et al., “Longitudinal assessment of mental disorders and neurological correlates,” JAMA Psychiatry, vol. 77, no. 2, pp. 184–192, 2020. doi: 10.1001/jamapsychiatry.2019.3253
[6] J. L. Cummings et al., “Neuropsychiatric syndromes in neurodegenerative diseases,” Nature Reviews Neurology, vol. 16, pp. 103–116, 2020. doi: 10.1038/s41582-019-0307-8
[7] H. S. Mayberg, “Brain circuitry in depression: Implications for neurology and psychiatry,” Neuron, vol. 107, no. 2, pp. 225–240, 2020. doi: 10.1016/j.neuron.2020.06.013
[8] R. S. Kessler et al., “The global burden of mental and neurological disorders,” The Lancet Psychiatry, vol. 8, no. 2, pp. 170–178, 2021. doi: 10.1016/S2215-0366(20)30434-8
[9] A. K. McIntyre et al., “Inflammation and neuropsychiatric disorders: Implications for clinical practice,” Molecular Psychiatry, vol. 26, pp. 134–148, 2021. doi: 10.1038/s41380-020-00966-8
[10] V. Patel et al., “Transforming mental health care globally,” World Psychiatry, vol. 20, no. 1, pp. 1–12, 2021. doi: 10.1002/wps.20819
[11] N. R. Drevets et al., “Neuroimaging abnormalities in mood disorders,” Biological Psychiatry, vol. 89, no. 2, pp. 109–122, 2021. doi: 10.1016/j.biopsych.2020.06.012
[12] J. W. Smoller et al., “Psychiatric genetics and the brain–mind interface,” Nature Reviews Neuroscience, vol. 22, pp. 537–555, 2021. doi: 10.1038/s41583-021-00476-8
[13] M. Menon, “Large-scale brain networks and psychopathology,” Trends in Cognitive Sciences, vol. 25, no. 3, pp. 234–246, 2021. doi: 10.1016/j.tics.2020.12.003
[14] S. E. Hyman, “Mental illness: Clinically relevant neuroscience,” Nature Medicine, vol. 27, pp. 128–135, 2021. doi: 10.1038/s41591-020-01168-7
[15] J. K. Raison et al., “Neuroimmune mechanisms of depression,” Nature Reviews Immunology, vol. 22, pp. 1–13, 2022. doi: 10.1038/s41577-021-00589-4
[16] K. J. Friston et al., “The free-energy principle in neuroscience and psychiatry,” Nature Reviews Neuroscience, vol. 23, pp. 307–322, 2022. doi: 10.1038/s41583-022-00560-9
[17] A. Abi-Dargham and G. Horga, “The search for biomarkers in psychiatric disorders,” Nature Medicine, vol. 28, pp. 225–234, 2022. doi: 10.1038/s41591-021-01640-9
[18] L. M. Collins et al., “Precision psychiatry: Opportunities and challenges,” The Lancet Psychiatry, vol. 9, no. 1, pp. 78–87, 2022. doi: 10.1016/S2215-0366(21)00342-4
[19] B. A. Arnedo et al., “Machine learning in neuropsychiatry: Clinical applications,” Nature Medicine, vol. 29, pp. 54–63, 2023. doi: 10.1038/s41591-022-02112-7
[20] World Health Organization, “Global report on neurological disorders: Intersections with mental health,” WHO, 2023. doi: 10.4060/cc1234en
